Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by François Dabis
Interpretation of Genotype and Pharmacokinetics for Resistance to Fosamprenavir-Ritonavir-Based Regimens in Antiretroviral-Experienced Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Pharmacokinetics of Etravirine Combined With Atazanavir/Ritonavir and a Nucleoside Reverse Transcriptase Inhibitor in Antiretroviral Treatment-Experienced, HIV-1-Infected Patients
AIDS Research and Treatment
Immunology
Public Health
Allergy
Environmental
Dermatology
Infectious Diseases
Occupational Health
An Observational Study in an Urban Ugandan Clinic Comparing Virological Outcomes of Patients Switched From First-Line Antiretroviral Regimens to Second-Line Regimens Containing Ritonavir-Boosted Atazanavir or Ritonavir-Boosted Lopinavir
BMC Infectious Diseases
Infectious Diseases
Long-Term Safety and Effectiveness of Lopinavir/Ritonavir in Antiretroviral-Experienced HIV-1-infected Children
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Pharmacokinetics and 48-Week Safety and Antiviral Activity of Fosamprenavir-Containing Regimens in HIV-infected 2- To 18-Year-Old Children
Pediatric Infectious Disease Journal
Child Health
Infectious Diseases
Pediatrics
Perinatology
Microbiology
Predictive Genotypic Algorithm for Virologic Response to Lopinavir-Ritonavir in Protease Inhibitor-Experienced Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
PIN65 Cost-Effectiveness of First-Line Antiretroviral Regimens for Human Immunodeficiency Virus (HIV) in Colombia: An Analysis of Lopinavir/Ritonavir (LPV/R) and Darunavir Plus Ritonavir (DRV+RTV) in Treatment-Naïve Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Resistance Analyses in HIV Infected Patients With a History of Multiple Antiretroviral Treatment Regimens
Sexually Transmitted Infections
Dermatology
Infectious Diseases
HIV-1 Integrase Resistance Among Antiretroviral Treatment Naive and Experienced Patients From Northwestern Poland
BMC Infectious Diseases
Infectious Diseases
